Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 3, 2007, Pages 698-701

  Campos, José ^a,b   Ferech, Matus ^c   Lázaro, Edurne ^d   de Abajo, Francisco ^d   Oteo, Jesús ^a   Stephens, Peter ^e   Goossens, Herman ^c,f  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CSIC   (Spain)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Division de Farmacoepidemiologia y Farmacovigilancia   (Spain)

^e IQVIA   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic resistance; ESAC; European Surveillance of Antimicrobial Consumption; Self antibiotic medication

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ENZYME INHIBITOR; ERYTHROMYCIN; FOSFOMYCIN; LEVOFLOXACIN; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; NORFLOXACIN; SPIRAMYCIN; TELITHROMYCIN;

AMBULATORY CARE; ARTICLE; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; HUMAN; OUTPATIENT; OUTPATIENT CARE; POSTMARKETING SURVEILLANCE; PRESCRIPTION; REIMBURSEMENT; SPAIN;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; COMMERCE; DRUG UTILIZATION; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; SPAIN;

EID: 34548138984     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm248     Document Type: Article

References (11)

1. The Copenhagen Recommendations Report from the Invitational EU Conference on the Microbial Threat. Copenhagen, Denmark, September 1998. Copenhagen: Ministry of Health, Ministry of Food, Agriculture and Fisheries, 1998.
2. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and assodation with resistance: A cross-national database study. Lancet 2005; 365: 579-87.
3. Vander Stichele R, Elseviers M, Ferech M et al. European Surveillance of Antimicrobial Consumption (ESAC): Data collection performance and methodological approach. Br J Clin Pharmacol 2004, 58: 419-28.
4. Oteo J, Lázaro E, de Abajo FJ et al. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 2005; 11: 546-53.
5. Oteo J, Lázaro E, de Abajo FJ et al. Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001-2003): Decreasing penicillin resistance in children's isolates. J Clin Microbiol 2004; 42 5571-7.
6. Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JG et al. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis 2006; 12: 452-9.
7. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-3.
8. Lázaro E, Madurga-M, de Abajo FJ. Evolución del consumo de antibióticos an España, 1985-2000. Med Clin 2002; 118: 561-8.
9. WHO Collaborating Contre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. WHO, Oslo, Norway, 2006.
10. The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis, LSE Health and Social Care, London School of Economics and Political Science, January 2004. http://www.lse.ac.uk/collections/LSEHeath/pdf/Workingpaper/Paper.pdf (5 March 2007, date last accessed).
11. Grigoryan L, Burgerhof JG, Haaijer-Ruskamp FM et al. Is self-medication with antibiotics in Europe driven by prescribed use? J Antimicrob Chemother 2007;59: 152-6.